company

AIRGENIC AS

1341 SLEPENDEN

Return on Equity
2,55 %
Current Ratio
6,37
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue6 406 000
Net Income91 000
Total Assets4 228 000
Total Equity3 564 000
Income (NOK)2022
Revenue6 406 000
Expenditure6 454 000
Operating Profit−48 000
Financial Income186 000
Financial Costs47 000
Financial Balance139 000
Earnings Before Tax91 000
Tax0
Net Income91 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets4 228 000
Total Assets4 228 000
Total Retained Equity0
Total Equity3 564 000
Total Long-Term Debt0
Total Current Debt664 000
Total Equity and Debt4 228 000
Cash flow (NOK)2022
Sales Income6 406 000
Other Income0
Revenue6 406 000
Cost of Goods Sold2 257 000
Salary Costs3 208 000
Depreciation0
Impairment0
Expenditure6 454 000
Operating Profit−48 000
Financial Income186 000
Financial Costs47 000
Financial Balance139 000
Dividends0
Net Income91 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock1 318 000
Total Investments0
Cash, Bank2 385 000
Total Current Assets4 228 000
Total Assets4 228 000
Total Equity3 564 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors74 000
Unpaid Taxes336 000
Dividends0
Other Current Debt254 000
Total Current Debt664 000
Total Equity and Debt4 228 000
Financial indicators2022
Return on Equity2,55 %
Debt-to-Equity Ratio0
Operating Profit Margin−0,75 %
Current Ratio6,37
Quick Ratio−6,46
Equity Ratio0,84
Gross Profit Margin64,77 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English